Table 3.
Comparison of clinical data in and outside Wuhan.
| Wuhan |
Outside Wuhan |
||||||
|---|---|---|---|---|---|---|---|
| Study 1 [9] | Study 2 [11] | Study 3 [139] | Study 4 [10] | Study 5 [134] | Study 6 [140] | Study 7 [141] | |
| Hospital | Jin Yin-tan Hospital | Jin Yin-tan Hospital | Union hospital in Wuhan | Zhongnan Hospital of Wuhan University | Guangzhou Eighth People's Hospital | Hospitals in Hainan province | 10 designated hospitals in Shaanxi province |
| Study Duration | 12/2019−2/1/2020 | 1/1−20/1/2020 | 16/1−29/1/2020 | 1/1−28/1/2020 | 10/1−24/2/2020 | 22/1−13/2/2020 | 23/1−7/3−2020 |
| Case Numble | 41 | 99 | 69 | 138 | 291 | 168 | 134 |
| Any comorbidity | 13 (32 %) | 50 (51 %) | … | 64 (46.4 %) | … | … | … |
| Diabetes | 8 (20 %) | 13 (13 %) | 7 (10 %) | 14 (10.1 %) | 22 (7.6 %) | 12 (7.1 %) | 9 (6.7 %) |
| Hypertension | 6 (15 %) | 40 (40 %) | 9 (13 %) | 43 (31.2 %) | 54 (18.5 %) | 24 (14.3 %) | 20 (14.9 %) |
| Cardiovascular disease | 6 (15 %) | 8 (12 %) | 20 (14.5 %) | 15 (5.1 %) | 12 (7.1 %) | 6 (4.5 %) | |
| Chronic obstructive pulmonary disease | 1 (2%) | 1 (1 %) | 4 (6 %) | 4 (2.9 %) | … | 10 (6%) | 5 (3.7 %) |
| Malignancy | 1 (2%) | 1 (1 %) | 4 (6 %) | 10 (7.2 %) | … | 2 (1.2 %) | 5 (3.7 %) |
| Chronic liver disease | 1 (2%) | 11 (11 %) | 1 (1%) | 4 (2.9 %) | … | 6 (3.6 %) | 5 (3.7 %) |
| Complications | |||||||
| Acute respiratory distress syndrome | 12 (29 %) | 17 (17 %) | … | 27 (19.6 %) | … | 17 (10.1 %) | 3 (2.2 %) |
| Acute cardiac injury | 5 (12 %) | … | … | 10 (7.2 %) | 15 (5.1 %) | 4 (2.4 %) | … |
| Acute kidney injury | 3 (7 %) | 3 (3 %) | … | 5 (3.6 %) | … | 6 (3.6 %) | 3 (2.2 %) |
| Secondary infection | 4 (10 %) | 5 (5%) | … | … | … | 7 (4.2 %) | 32 (23.9 %) |
| Shock | 3 (7%) | 4 (4%) | … | 12 (8.7 %) | … | 12 (7.1 %) | 1 (0.7 %) |
| Prognosis | |||||||
| Hospitalization | 7 (17 %) | 57 (58 %) | 44 (65.7 %) | 85 (61.6 %) | … | 160 (95.2 %) | 123 (91.8 %) |
| Discharge | 28 (68 %) | 31 (31 %) | 18 (26.9 %) | 47 (34.1 %) | … | 6 (3.6 %) | 9 (6.7 %) |
| Death | 6 (15 %) | 11 (11 %) | 5 (7.5 %) | 6 (4.3 %) | 1 (0.3 %) | 2 (1.2 %) | 1 (0.7 %) |